SpringerProtocols: Abstract: Expression, Purification, and Detection of Novel Streptococcal Superantigens

Expression, Purification, and Detection of Novel Streptococcal Superantigens

By: John K. McCormick³, Patrick M. Schlievert⁴

Abstract

Full Text

Download PDF (171K)

Superantigens (SAgs) are a class of bacterial or viral proteins that aberrantly alter immune system function through simultaneous interaction with lateral surfaces of major histocompatibility (MHC) class II molecules on antigen presenting cells, and to particular variable regions of the T-cell antigen receptor (TCR) β-chain. Among the secreted virulence factors from group A streptococci are the streptococcal pyrogenic exotoxins (SPEs), also commonly known as erythrogenic toxins or scarlet fever toxins. Together with the enterotoxins and toxic shock syndrome toxin-1 (TSST-1) from Staphylococcus aureus, the SPEs belong to a larger family of related exotoxins collectively known as the “pyrogenic toxin” class of superantigens, which share functional activities, similar amino acid sequences, and conserved three-dimensional structures (1,2). Due to their notable association with scarlet fever and streptococcal toxic shock syndrome (TSS), SPE A (3,4) and SPE C (5) are generally considered to be the prototypical streptococcal superantigens.

Affiliation(s): (3) The Lawson Health Research Institute, and Department of Microbiology and Immunology, The University of Western Ontario, London, Ontario, Canada
(4) Department of Microbiology, University of Minnesota Medical School, Minneapolis, MN

Book Title: Superantigen Protocols

Series: Methods in Molecular Biology | Volume: 214 | Pub. Date: Oct-23-2002 | Page Range: 33-43 | DOI: 10.1385/1-59259-367-4:033

Subject: Immunology

References

Download References

1.	Kotb, M. (1995) Bacterial pyrogenic exotoxins as superantigens. Clin. Microbiol. Rev. 8, 411–426.

2.	McCormick, J. K., Yarwood, J. M., and Schlievert, P. M. (2001) Toxic shock syndrome and bacterial superantigens: an update. Ann. Rev. Microbiol. 55, 77–104.

3.	Weeks, C. R., and Ferretti, J. J. (1986) Nucleotide sequence of the type A streptococcal exotoxin (erythrogenic toxin) gene from Streptococcus pyogenes bacteriophage T12. Infect. Immun. 52, 144–150.

4.	Johnson, L. P., L’Italien, J. J., and Schlievert, P. M. (1986) Streptococcal pyrogenic exotoxin type A (scarlet fever toxin) is related to Staphylococcus aureus enterotoxin B. Mol. Gen. Genet. 203, 354–356.

5.	Goshorn, S. C. and Schlievert, P. M. (1988) Nucleotide sequence of streptococcal pyrogenic exotoxin type C. Infect. Immun. 56, 2518–2520.

6.	Ferretti, J. J., McShan, W. M., Ajdic, D., Savic, D. J., Savic, G., Lyon, K., et al. (2001) Complete genome sequence of an M1 strain of Streptococcus pyogenes. Proc. Natl. Acad. Sci. USA 98, 4658–663.

7.	Proft, T., Moffatt, S. L., Berkahn, C. J., and Fraser, J. D. (1999) Identification and characterization of novel superantigens from Streptococcus pyogenes. J. Exp. Med. 189, 89–102.

8.	Proft, T., Arcus, V. L., Handley, V., Baker, E. N., and Fraser, J. D. (2001) Immunological and Biochemical Characterization of Streptococcal Pyrogenic Exotoxins I and J (SPE-I and SPE-J) from Streptococcus pyogenes. J. Immunol. 166, 6711–6719.

9.	McCormick, J. K., Pragman, A. A., Stolpa, J. C., Leung, D. Y., and Schlievert, P. M. (2001) Functional characterization of streptococcal pyrogenic exotoxin J, a novel superantigen. Infect. Immun. 69, 1381–1388.

10.	Mollick, J. A., Miller, G. G., Musser, J. M., Cook, R. G., Grossman, D., and Rich, R. R. (1993) A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C. J. Clin. Invest. 92, 710–719.

11.	Kamezawa, Y., Nakahara, T., Nakano, S., Abe, Y., Nozaki-Renard, J., and Isono, T. (1997) Streptococcal mitogenic exotoxin Z, a novel acidic superantigenic toxin produced by a T1 strain of Streptococcus pyogenes. Infect. Immun. 65, 3828–3833.

12.	Proft, T., Moffatt, S. L., Weller, K. D., Paterson, A., Martin, D., and Fraser, J. D. (2000) The streptococcal superantigen SMEZ exhibits wide allelic variation, mosaic structure, and significant antigenic variation. J. Exp. Med. 191, 1765–1776.

13.	Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.

14.	Schlievert, P. M., Shands, K. N., Dan, B. B., Schmid, G. P., and Nishimura, R. D. (1981) Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J. Infect. Dis. 143, 509–516.

15.	Kum, W. W., Laupland, K. B., See, R. H., and Chow, A. W. (1993) Improved purification and biologic activities of staphylococcal toxic shock syndrome toxin 1. J. Clin. Microbiol. 31, 2654–2660.

16.	Arcus, V. L., Proft, T., Sigrell, J. A., Baker, H. M., Fraser, J. D., and Baker, E. N. (2000) Conservation and variation in superantigen structure and activity highlighted by the three-dimensional structures of two new superantigens from Streptococcus pyogenes. J. Mol. Biol. 299, 157–168.

17.	Ouchterlony, O. (1962) Diffusion-in-gel methods for immunoogical analysis. Prog. Allergy 6, 30.

18.	Li, Y., Li, H., Dimasi, N., McCormick, J. K., Martin, R., Schuck, P., et al. (2001) Crystal structure of a superantigen bound to the highaffinity, zinc-dependent site on MHC class II. Immunity 14, 93–104. <Occurrence Type="DOI"><Handle>10.1016/S1074-7613(01)00092-9</Handle></Occurrence>

Comments (Loading...)

Post comment/View all comments